Industry

DUBLIN–(BUSINESS WIRE)–The “Understanding And Implementing A Quality By Design (Qbd) Program” webinar has been added to ResearchAndMarkets.com’s offering. The benefits of applying the QbD principles in the pharmaceutical industry have been well advertised. Most important are the direct benefits to our primary customer; the patient. Per Janet Woodcock M.D. Director, Center for Drug Evaluation and … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Renal Dialysis Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update” report has been added to ResearchAndMarkets.com’s offering. Scope Extensive coverage of the Renal dialysis equipment under development The report reviews details of major pipeline products which includes, product description, licensing and collaboration details … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Devices Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering. The ophthalmic devices market is projected to register a CAGR of 4.2% over the forecast period (2022-2027). Companies Mentioned Alcon Inc. Bausch Health Companies Inc. Carl Zeiss Meditec AG EssilorLuxottica SA HAAG-Streit Group … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Psychedelic Drugs Market – Growth, Trends, Covid-19 Impact, and Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering. The psychedelic drugs market is expected to register a CAGR of 7% during the forecast period. Companies Mentioned Jazz Pharmaceuticals Hikma Pharmaceuticals Celon Pharmaceuticals Cybin Corp. Pfizer Inc. Numinus Mind care Health Inc. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Retinal Disorder Treatment Market Research Report by Type (Diabetic Retinopathy and Macular Degeneration), Dosage Form, Distribution Channel, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Retinal Disorder Treatment Market size was estimated at … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Organ Preservation Market Share, Size, Trends, Industry Analysis Report, By Solution; By Technique; By End-User; By Organ Type; By Region; Segment Forecast, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering. The global organ preservation market size is expected to reach USD 410.24 million by 2030 Rising geriatric population and the increase … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Hospital Acquired Infection Control Market Research Report by Type (Consumables, Disinfectants, and Disinfectors), Pathogen Type, Indication, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Hospital Acquired Infection Control Market size was … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Oncology Based In-Vivo CRO Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global oncology based in-vivo CRO market reached a value of US$ 1.05 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 1.69 Billion … [Read more…]

ALAMEDA, Calif.–(BUSINESS WIRE)–#CRISPR–Scribe Therapeutics Inc., a molecular engineering company creating the most advanced technologies for CRISPR-based genetic medicine, today announced its participation in the virtual Biopharma Private Company Connect event hosted by SVB Securities on July 20-21, 2022. Company executives, including CEO and co-founder Benjamin Oakes, PhD, and Chief Financial Officer David Parrot, will hold … [Read more…]

Following Agreement With Alladapt Immunotherapeutics, Inc. LAVAL, Quebec–(BUSINESS WIRE)–#Alladapt—Altasciences’ formulation, manufacturing, and analytical services facilities in Philadelphia, PA, are undergoing further expansion. Altasciences—an integrated CRO/CDMO offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies—is building client‑dedicated facilities for Alladapt Immunotherapeutics, Inc. (“Alladapt”), a private, clinical-stage biopharmaceutical company developing prescription … [Read more…]